“Hereditary angioedema type 1, limitations for prophylactic therapy with Lanadelumab: Regarding a case”, Rev Alerg Mex, vol. 71, no. 4, pp. 264–267, Dec. 2024, doi: 10.29262/ram.v71i4.1323.